News Focus
News Focus
icon url

Dr Bala

05/10/22 4:14 PM

#470292 RE: exwannabe #470284

Totally nonsensical speculations. DCVax-L will be approved by all the RAs based on the results presented today.
icon url

hoffmann6383

05/10/22 4:23 PM

#470304 RE: exwannabe #470284

These are the kind of results that will get approval from the FDA, MHRA, Health Canada and the EMA.

icon url

muee88

05/10/22 4:23 PM

#470305 RE: exwannabe #470284

“The patients randomized to placebo live longer than those randomized to DCVax-L.”

Would you mind supporting your claim? Please post a screenshot of one of the slides that allegedly supports your position and provide a brief explanation why that slide supports your position.
icon url

CherryTree1

05/10/22 4:34 PM

#470318 RE: exwannabe #470284

OK
. . . then please point me to the chart

The patients randomized to placebo live longer than those randomized to DCVax-L.

https://virtualtrials.org/dcvax/dcvax.pdf
there are no placebo patients only that received DCVAX later in the trial after showing recurrence and that population was comparted to recurrent GBM SOC patents and DCVAX is show to be of considerable benefit to them.
icon url

GoodGuyBill

05/10/22 5:32 PM

#470363 RE: exwannabe #470284

In the last year or so, your position was we'll never see TLD. Now that TLD was presented, the new position is we'll never see a BLA or if one is submitted it will cause LP's undoing. Utter bs.